Cargando…

Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim(®) 160U) in South Korea from 2011 to 2015

INTRODUCTION: Hepatitis A, caused by hepatitis A virus (HAV), is one of the leading causes of acute hepatitis in South Korea. Avaxim(®) 160U is an inactivated hepatitis A vaccine that has been proven to be highly effective and well tolerated. It is licensed for use in more than 90 countries, and was...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, HeeSoo, Oh, Yongho, Thollot, Yael, Bravo, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374234/
https://www.ncbi.nlm.nih.gov/pubmed/30673992
http://dx.doi.org/10.1007/s40121-019-0230-9

Ejemplares similares